Savara (SVRA) Current Leases (2016 - 2018)

Savara's (SVRA) quarterly Current Leases came in at $41000.0 in Q4 2018, down 84.53% year-on-year from $265000.0 in Q4 2017, and down 87.11% on a QoQ basis from $318000.0 in Q3 2018.

Savara (SVRA) Current Leases (2016 - 2018) Analysis & Trends

Savara (SVRA) has 3 years of Current Leases data on file, last reported at $41000.0 in Q4 2018.

  • On a quarterly basis, Current Leases fell 84.53% year-over-year to $41000.0 in Q4 2018; TTM through Dec 2018 was $41000.0, a 84.53% decrease from a year earlier, with the FY2018 full-year figure at $41000.0, down 84.53% from the prior year.
  • Current Leases for Q4 2018 stood at $41000.0, down from $318000.0 in the prior quarter.
  • Over the last five years, Current Leases for SVRA reached as high as $719000.0 in Q2 2017 and fell as low as $21000.0 in Q1 2018.
  • Historically, Current Leases has averaged $298625.0 across 3 years, with a median of $291500.0 in 2017.
  • On a YoY basis, Current Leases climbed as much as 20.0% in 2018 and fell as far as 84.53% in 2018.
  • Year by year, Current Leases stood at $442000.0 in 2016, then tumbled by 40.05% to $265000.0 in 2017, then sank by 84.53% to $41000.0 in 2018.
  • Per Business Quant data, the three most recent Current Leases figures were $41000.0 in Q4 2018, $318000.0 in Q3 2018, and $318000.0 in Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 531,233.95
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 20.58 Mn
4 NuCana 279.75 Bn 279.75 Bn - 872,589.03
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 720.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 11.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 16.61 Mn
10 Savara 1.24 Bn 1.24 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2018 41,000.00
Sep 30, 2018 318,000.00
Jun 30, 2018 318,000.00
Mar 31, 2018 21,000.00
Dec 31, 2017 265,000.00
Sep 30, 2017 265,000.00
Jun 30, 2017 719,000.00
Dec 31, 2016 442,000.00